Factors associated with drug resistance mutations among antiretroviral therapy-experienced adolescents living with HIV in South Rift Valley, Kenya

Abstract: Background: Antiretroviral therapy (ART) has significantly improved survival among people living with human immunodeficiency virus (PLHIV), yet drug resistance mutations (DRMs) continue to threaten treatment outcomes globally. Adolescents remain particularly vulnerable to DRMs due to biological, behavioural and structural factors. However, little is known about the factors associated with DRMs in the South Rift Valley (SRV) of Kenya. Aim: To assess factors associated with DRMs among ART-experienced adolescents in SRV. Setting: Eighty-two HIV clinics located in Nandi, Kericho, Bomet and Narok counties in Kenya’s SRV region. Methods: A retrospective cohort study was conducted among 226 ART-experienced adolescents aged 10–19 years with virologic failure, selected through simple random sampling. Plasma samples were genotyped to identify HIVDRMs using the Stanford HIV Drug Resistance database. Demographic, clinical and behavioural information was obtained from medical records and questionnaires. Descriptive statistics, Chi-square tests and logistic regression were performed to determine factors associated with DRMs. Results: The median age was 17 years (IQR: 15–18); 51.3% was male and 65% was orphans. Bivariate analysis identified several factors significantly associated with DRMs: ART duration (p = 0.030), enhanced adherence counselling (EAC) sessions (p = 0.001), ART regimen type (p = 0.001), CD4 count (p = 0.030), caregiver occupation (p = 0.029), and orphan status (p = 0.049). Conclusion: Longer ART duration, multiple EAC sessions and use of non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens were associated with DRMs. These findings underscore the need for strengthened adherence support, early regimen optimisation and targeted interventions for adolescents at higher risk of resistance. Contribution: The study provides evidence to guide clinical and policy strategies aimed at improving ART outcomes among adolescents in Kenya.

Authors

Institutions

Publication Details

Journal
Journal of Public Health in Africa
Published
2025-11-27
DOI
https://doi.org/10.4102/jphia.v16i4.1488
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors associated with drug resistance mutations among antiretroviral therapy-experienced adolescents living with HIV in South Rift Valley, Kenya

Argwings Odhiambo Miruka, Louisa Ndunyu, Patrick Onyango
Journal of Public Health in Africa
HIV/AIDS drug development and treatment
article

Factors associated with drug resistance mutations among antiretroviral therapy-experienced adolescents living with HIV in South Rift Valley, Kenya

Argwings Odhiambo Miruka, Louisa Ndunyu, Patrick Onyango
article en

Abstract

Abstract: Background: Antiretroviral therapy (ART) has significantly improved survival among people living with human immunodeficiency virus (PLHIV), yet drug resistance mutations (DRMs) continue to threaten treatment outcomes globally. Adolescents remain particularly vulnerable to DRMs due to biological, behavioural and structural factors. However, little is known about the factors associated with DRMs in the South Rift Valley (SRV) of Kenya. Aim: To assess factors associated with DRMs among ART-experienced adolescents in SRV. Setting: Eighty-two HIV clinics located in Nandi, Kericho, Bomet and Narok counties in Kenya’s SRV region. Methods: A retrospective cohort study was conducted among 226 ART-experienced adolescents aged 10–19 years with virologic failure, selected through simple random sampling. Plasma samples were genotyped to identify HIVDRMs using the Stanford HIV Drug Resistance database. Demographic, clinical and behavioural information was obtained from medical records and questionnaires. Descriptive statistics, Chi-square tests and logistic regression were performed to determine factors associated with DRMs. Results: The median age was 17 years (IQR: 15–18); 51.3% was male and 65% was orphans. Bivariate analysis identified several factors significantly associated with DRMs: ART duration (p = 0.030), enhanced adherence counselling (EAC) sessions (p = 0.001), ART regimen type (p = 0.001), CD4 count (p = 0.030), caregiver occupation (p = 0.029), and orphan status (p = 0.049). Conclusion: Longer ART duration, multiple EAC sessions and use of non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens were associated with DRMs. These findings underscore the need for strengthened adherence support, early regimen optimisation and targeted interventions for adolescents at higher risk of resistance. Contribution: The study provides evidence to guide clinical and policy strategies aimed at improving ART outcomes among adolescents in Kenya.

Journal of Public Health in AfricaVol. 16(4)
Maseno University (KE)
Openalex Percentile: Top 57%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.